Abstract
The COVID-19 vaccine development is currently central news globally. With recently reported successes, however, the focus is shifting from the very availability of a vaccine to manufacturing and distribution aspects. It is the pharmaceutical sector that will be playing the key role in freeing the world from the disease. A business expert argues that companies should embrace the corporate social responsibility ethos to subside their corporate interests for the greater benefit of the humanity.